Lipocine Inc.
USD2.49
+0.00 (+-0.40%)
CEO
Mahesh V. Patel
IPO Date
2013-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.48
Prev. Close
$2.49
Day Low
$2.46
Day High
$2.50
52W Low
$1.81
52W High
$12.37
Market Cap
$0.01B
Volume
0.01M
| 3119.5 |
| 31 Dec 2023 | FY | 456.9% | 573.6% | -80.3% | -71.1% | 0.00 | 8.69 | -0.9 |
| 31 Dec 2022 | FY | -1611.4% | -2151.7% | -30.2% | -28.7% | 0.00 | 20.34 | -3.1 |
| 31 Dec 2021 | FY | 52.5% | -3.9% | -1.4% | -1.2% | 0.05 | 8.26 | -87.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -136.7% | -82.7% | 0.36 | 3.85 | -3.6 |
| 31 Dec 2019 | FY | -4426.5% | -7883.7% | -206.9% | -66.2% | 1.14 | 3.95 | -0.8 |
| 31 Dec 2018 | FY | 100.0% | -2724.1% | -123.6% | -55.9% | 1.09 | 4.63 | -2.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -110.6% | -82.9% | 0.00 | 3.97 | -3.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -72.9% | -69.4% | 0.00 | 20.52 | -3.5 |
| -4.6 |
| 30 Sept 2025 | Q3 | 100.0% | -2781.5% | -22.5% | -19.8% | 0.00 | 8.25 | -1.2 |
| 30 Jun 2025 | Q2 | -243.1% | -354.1% | -12.9% | -11.9% | 0.00 | 12.71 | -1.9 |
| 31 Mar 2025 | Q1 | 100.0% | -1986.8% | -9.7% | -9.1% | 0.00 | 15.64 | -2.3 |
| 31 Dec 2024 | Q4 | 100.0% | 51.0% | 8.5% | 7.9% | 0.00 | 14.75 | 3.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.6% | -10.7% | 0.00 | 12.97 | -2.7 |
| 30 Jun 2024 | Q2 | -1993.1% | -3426.2% | -14.5% | -13.3% | 0.00 | 12.56 | -3.4 |
| 31 Mar 2024 | Q1 | 100.0% | 46.1% | 14.7% | 13.8% | 0.00 | 16.99 | 2.0 |
| 31 Dec 2023 | Q4 | 100.0% | -1055.7% | -11.2% | -9.9% | 0.00 | 8.69 | -1.6 |